Literature DB >> 17762515

DNA fragmentation and oxidative stress in the hippocampal formation: a bridge between 3,4-methylenedioxymethamphetamine (ecstasy) intake and long-lasting behavioral alterations.

Giada Frenzilli1, Michela Ferrucci, Filippo Sean Giorgi, Fabio Blandini, Marco Nigro, Stefano Ruggieri, Luigi Murri, Antonio Paparelli, Francesco Fornai.   

Abstract

Intake of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) in humans leads to marked behavioral alterations. In a recent paper, we demonstrated that chronic MDMA intake produces a latent hippocampal hyperexcitability that parallels a reduced threshold for limbic seizures and a slowing of electroencephalographic activity. These phenomena suggest an alteration in hippocampal function. So far, only a few studies have focused on the hippocampal formation as a potential target for the effects induced by MDMA. In this study we sought to evaluate whether the intrinsic cells of the hippocampus might be modified chronically by ecstasy intake. In particular, we examined whether administration of MDMA, at doses producing hippocampal hyperexcitability also produces rearrangements of DNA strands measured by the comet assay. We found that MDMA, at very low doses, comparable with those self-administered by humans, produces acute oxidative stress and DNA single and double-strand breaks, which persist together with long-lasting metabolic changes in the hippocampal formation. These persisting effects are accompanied by behavioral sensitization, reduced seizure threshold and long-lasting slowing of electroencephalographic activity, and hyperexcitability of the hippocampus, without affecting the basal ganglia. The present data indicate that the intake of very low doses of MDMA, comparable to those consumed by humans, produces selective hippocampal alterations which may underlie cognitive impairment and seizure susceptibility.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17762515     DOI: 10.1097/FBP.0b013e3282d518aa

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  13 in total

1.  MDMA decreases glutamic acid decarboxylase (GAD) 67-immunoreactive neurons in the hippocampus and increases seizure susceptibility: Role for glutamate.

Authors:  Courtney L Huff; Rachel L Morano; James P Herman; Bryan K Yamamoto; Gary A Gudelsky
Journal:  Neurotoxicology       Date:  2016-10-20       Impact factor: 4.294

2.  Methylenedioxymethamphetamine inhibits mitochondrial complex I activity in mice: a possible mechanism underlying neurotoxicity.

Authors:  Elena Puerta; Isabel Hervias; Beatriz Goñi-Allo; Steven F Zhang; Joaquín Jordán; Anatoly A Starkov; Norberto Aguirre
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

3.  Residual social, memory and oxytocin-related changes in rats following repeated exposure to γ-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination.

Authors:  Petra S van Nieuwenhuijzen; Leonora E Long; Glenn E Hunt; Jonathon C Arnold; Iain S McGregor
Journal:  Psychopharmacology (Berl)       Date:  2010-08-21       Impact factor: 4.530

4.  Behavioral and Stereological Analysis of the Effects of Intermittent Feeding Diet on the Orally Administrated MDMA ("ecstasy") in Mice.

Authors:  Zeinab Ebrahimian; Zeinab Karimi; Mohammad Javad Khoshnoud; Mohammad Reza Namavar; Bahram Daraei; Mohsen Raza Haidari
Journal:  Innov Clin Neurosci       Date:  2017-02-01

5.  Region-specific DNA alterations in focally induced seizures.

Authors:  Emanuela Cantafora; Filippo Sean Giorgi; Giada Frenzilli; Vittoria Scarcelli; Carla L Busceti; Marco Nigro; Margherita Bernardeschi; Francesco Fornai
Journal:  J Neural Transm (Vienna)       Date:  2014-04-20       Impact factor: 3.575

Review 6.  Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview.

Authors:  João Paulo Capela; Helena Carmo; Fernando Remião; Maria Lourdes Bastos; Andreas Meisel; Félix Carvalho
Journal:  Mol Neurobiol       Date:  2009-04-17       Impact factor: 5.590

7.  Effects of acute and chronic administration of fenproporex on DNA damage parameters in young and adult rats.

Authors:  Cinara L Gonçalves; Gislaine T Rezin; Gabriela K Ferreira; Isabela C Jeremias; Mariane R Cardoso; Samira S Valvassori; Bruna J P Munhoz; Gabriela D Borges; Bruno N Bristot; Daniela D Leffa; Vanessa M Andrade; João Quevedo; Emilio L Streck
Journal:  Mol Cell Biochem       Date:  2013-05-01       Impact factor: 3.396

8.  Neurotoxic Effects of 5-MeO-DIPT: A Psychoactive Tryptamine Derivative in Rats.

Authors:  Karolina Noworyta-Sokołowska; Katarzyna Kamińska; Grzegorz Kreiner; Zofia Rogóż; Krystyna Gołembiowska
Journal:  Neurotox Res       Date:  2016-07-26       Impact factor: 3.911

9.  Neurochemical and Neurotoxic Effects of MDMA (Ecstasy) and Caffeine After Chronic Combined Administration in Mice.

Authors:  Anna Maria Górska; Katarzyna Kamińska; Agnieszka Wawrzczak-Bargieła; Giulia Costa; Micaela Morelli; Ryszard Przewłocki; Grzegorz Kreiner; Krystyna Gołembiowska
Journal:  Neurotox Res       Date:  2017-11-13       Impact factor: 3.911

Review 10.  Epigenetic Effects Induced by Methamphetamine and Methamphetamine-Dependent Oxidative Stress.

Authors:  Fiona Limanaqi; Stefano Gambardella; Francesca Biagioni; Carla L Busceti; Francesco Fornai
Journal:  Oxid Med Cell Longev       Date:  2018-07-22       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.